A US man has bought the domain name, Ebola .com and he plans to sell it for $150,000 (24,614,980.68)
Ebola might have killed over 4,000 people but one man hopes that it would make him very rich through the website, Ebola.com.
Jon Schultz is the President of Nevada-based Blue String Ventures and the owner of the Ebola.com domain and he intends to part with it for $150,000 (24,614,980.68) or more as he says that the price is "is subject to change as the situation evolves."
He told CNBC:
"$150,000 is not a tremendous amount for a premium domain. The fact that this is a top news story makes it very reasonable, in our opinion, as many domains sell for seven figures. Just this year Whisky.com sold for $3.1 million and MI.com sold for $3.6 million."
"Ebola.com would be a great domain for a pharmaceutical company working on a vaccine or cure, a company selling pandemic or disaster-preparedness supplies, or a medical company wishing to provide information and advertise services,"
"There could be many other applications as well. With so many people concerned about the disease, any advertisement referring people to Ebola.com should get an excellent response."
Schultz is said to have bought Ebola.com in 2008 for $13,500 and along with his business partner Chris Hood, owns other domains such as BirdFlu.com and PotassiumIodide.com.
Ebola might have killed over 4,000 people but one man hopes that it would make him very rich through the website, Ebola.com.
Jon Schultz is the President of Nevada-based Blue String Ventures and the owner of the Ebola.com domain and he intends to part with it for $150,000 (24,614,980.68) or more as he says that the price is "is subject to change as the situation evolves."
He told CNBC:
"$150,000 is not a tremendous amount for a premium domain. The fact that this is a top news story makes it very reasonable, in our opinion, as many domains sell for seven figures. Just this year Whisky.com sold for $3.1 million and MI.com sold for $3.6 million."
"Ebola.com would be a great domain for a pharmaceutical company working on a vaccine or cure, a company selling pandemic or disaster-preparedness supplies, or a medical company wishing to provide information and advertise services,"
"There could be many other applications as well. With so many people concerned about the disease, any advertisement referring people to Ebola.com should get an excellent response."
Schultz is said to have bought Ebola.com in 2008 for $13,500 and along with his business partner Chris Hood, owns other domains such as BirdFlu.com and PotassiumIodide.com.
Posted by , Published at 5:53 AM and have
0
comments
No comments:
Post a Comment